top of page
Browse by category
Search

LUCIDITY trial to assess Avexitide in post-bariatric hypoglycaemia patients
Amylyx Pharmaceuticals plans to initiate a Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class...


PREVENT Study: Positive results of Avexitide in post-bariatric hypoglycaemia patients
Eiger BioPharmaceuticals has announced positive results from the Phase 2 PREVENT study of Avexitide in patients with severe...
Browse by tag





bottom of page